Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
BBNX6 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in BETA BIONICS INC
Yes. Farallon Capital Management holds 595,000 shares of BBNX (Beta Bionics), worth $9.3M, as of its Q2 2026 13F filing. It reduced the position by 3,012,920 shares (-83.5%) from Q1 2026. Farallon Capital Management has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.
Current Value
$9.3M
Current Shares
595,000
Total Value Change
-$31.5M
Total Shares Change
-2.7M
Quarter-by-Quarter History
Other major holders of BBNX: MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP